Scarica l'app Stockscreener
560.55
1.91%
-10.89
Dopo l'orario di chiusura:
560.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Marex Group plc Buys New Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
2 Predictions for Novo Nordisk in 2026 - The Motley Fool
What analysts say about Madrigal Pharmaceuticals Inc YDO1 stockHigh Beta Stocks & High Return Capital Strategies - earlytimes.in
Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells $10,297,597.50 in Stock - MarketBeat
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 24,800 Shares of Stock - MarketBeat
Braidwell LP Has $18.40 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Adage Capital Partners GP L.L.C. Buys 184,554 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Taub of Madrigal Pharmaceuticals sells $10.3 million in stock By Investing.com - Investing.com Canada
Madrigal Pharmaceuticals, Inc. $MDGL is Paulson & CO. Inc.'s Largest Position - MarketBeat
Madrigal Pharmaceuticals expands workforce with new equity grants to staff - MSN
Madrigal Pharmaceuticals Appoints New Chief Accounting Officer - TradingView
Key facts: B. Riley Raises Madrigal Price Target to $670; Directors File Form 144 - TradingView — Track All Markets
Madrigal Pharmaceuticals (MDGL) Sees Price Target Increase By B. - GuruFocus
Liver Fibrosis Market Expected to Gain Momentum Through 2034, According to DelveInsight | Madrigal Pharma, Akero Therapeutics, Sagimet Biosciences, Boehringer Ingelheim, Zealand Pharma, 89bio - Barchart.com
H.C. Wainwright Keeps Buy on Madrigal Pharmaceuticals (MDGL) on Strong Rezdiffra Uptake and F2/F3 MASH Patient Data - Insider Monkey
Invesco Ltd. Has $60.64 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
11 High Short Interest Stocks to Buy Right Now - Insider Monkey
Madrigal Pharmaceuticals Expands Workforce With New Equity Grants to Staff - MyChesCo
Madrigal Pharmaceuticals, Inc. $MDGL Holdings Increased by Stempoint Capital LP - MarketBeat
Marshall Wace LLP Acquires 52,319 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
2 Stocks Up Over 600% in the Past 3 Years With More Room to Run - Finviz
The Bull Case For Madrigal Pharmaceuticals (MDGL) Could Change Following New Two-Year Rezdiffra Cirrhosis Data - Sahm
Norges Bank Invests $53.41 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
JPMorgan Chase & Co. Buys 27,840 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells 2,400 Shares of Stock - MarketBeat
Madrigal Pharmaceuticals (MDGL): Rezdiffra’s Strong Launch Spurs Rethink of Blockbuster Potential and Current Valuation - Yahoo Finance
Why analysts remain bullish on Madrigal Pharmaceuticals Inc. stockGap Down & Entry and Exit Point Strategies - Newser
Madrigal Pharmaceuticals (NASDAQ:MDGL) CFO Sells $2,413,412.82 in Stock - MarketBeat
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,380,816, According to a Recent SEC Filing - marketscreener.com
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Madrigal Pharma EVP Dier sells $2.4m in MDGL stock By Investing.com - Investing.com Australia
Why Madrigal Pharmaceuticals Inc. (YDO1) stock signals breakout potentialPrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Madrigal (MDGL) Up 21.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Galmed Announces Grant of New Use Patents for the Combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra for Mash - marketscreener.com
Lobbying Update: $30,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Galmed announces grant of new use patents for the combination of Aramchol and Madrigal Pharmaceuticals - marketscreener.com
Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH - PR Newswire
Schroder Investment Management Group Grows Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by New York State Common Retirement Fund - MarketBeat
Can Madrigal Pharmaceuticals Inc. (YDO1) stock double in coming yearsWall Street Watch & Stock Portfolio Risk Control - Newser
Legal & General Group Plc Increases Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
How Madrigal Pharmaceuticals Inc. (YDO1) stock valuation compares with sectorWeekly Trade Review & Real-Time Buy Signal Notifications - Newser
Why analysts recommend Madrigal Pharmaceuticals Inc. (YDO1) stockWeekly Investment Recap & Fast Gain Stock Trading Tips - Newser
Will Madrigal Pharmaceuticals Inc. (YDO1) stock extend growth story2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
Madrigal Pharma EVP Dier sells $2.4m in MDGL stock - Investing.com
Madrigal Pharmaceuticals Insider Sold Shares Worth $2,413,416, According to a Recent SEC Filing - marketscreener.com
MDGL: Billion-dollar run rate, expanding prescriber base, and robust pipeline drive long-term growth - TradingView
Russell Investments Group Ltd. Increases Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
How Madrigal Pharmaceuticals Inc. (YDO1) stock performs in volatility spikesJuly 2025 Pullbacks & High Accuracy Investment Signals - Newser
Madrigal Pharmaceuticals (MDGL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Madrigal Pharmaceuticals (MDGL) Surged Following the Strong Launch and Execution of New Drug - Insider Monkey
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):